• Dr. Roscoe M. Moore, Jr. has been appointed Senior Advisor of VivoNex LLC which is headquartered in Coral Gables, Florida. VivoNex has a patented technology, NexDose, which electronically aids patient compliance with prescription medications. Poor patient adherence to therapy is a major issue world-wide. Poor adherence can cause severe medical and economic consequences in virtually every disease state (like cancer, diabetes, and HIV) treated by medical therapy. Dr. Moore is a former Assistant United States Surgeon General, and he has served as a Commissioner on the Maryland Health Care Commission, appointed by the Governor.

• On October 28, 2010, Dr. Roscoe M. Moore Jr. was an invited guest to attend a reception for United States Surgeon General Joycelyn Elders in Washington DC. The reception was held to help establish the Joycelyn Elders Chair in Sexual Health Education within the University of Minnesota Medical School. Dr. Elders began her medical residency training at Minnesota in 1960. She served as United States Surgeon General from 1993 until 1994. Dr. Elders was in attendance. Dr. Moore served as Assistant United States Surgeon General from 1995 until 2003, and as Chief Veterinary Medical Officer within the Commissioned Corps of the United States Public Health Service from 1989 until 1993 selected by Surgeon General C. Everett Koop.

• On October 21, 2010, Dr. Roscoe M. Moore, Jr. attended the Potomac Institute for Policy Studies 2010 Navigation Awards Dinner held in Washington DC. The Navigator Awards are so-named to reflect the belief that national leadership in science and technology is a never-ending process of finding the way ahead. Four people were honored with this year's award by the Potomac Institute at its annual dinner. They were: Mr. Elon Musk (CEO/CTO, Space Exploration Technologies, and CEO, Tesler Motors), The Honorable Arden L. Bement Jr. (Former Director, National Science Foundation), Dr. Jeffrey Wadsworth (President and CEO, Battelle Memorial Institute), and Dr. Gerald M. Edelman (Noble Laureate, and President, Neurosciences Research Foundation) . The Potomac Institute established in 1994 provides the United States Congress and the current Administration with non-partisan advice on science and technology and their effects on national policy. Dr. Moore has been a Senior Fellow with the Potomac Institute since 2003.

• On October 19, 2010, Dr. Roscoe M. Moore, Jr. was an invited guest to attend a reception in Washington, D.C. for the Minister of Health for Israel, Dr. Ronni Gamzu. Dr. Gamzu was on an official visit to meet with the U.S. Secretary for Health and Human Services. He is a board certified obstetrician and gynecologist, and holds advanced degrees in business and law. In addition, Dr. Gamzu has a Ph.D. in human reproduction. He was appointed to his current position in May 2010. The reception honoring Dr. Gamzu was sponsored by the Smokler Center for Health Policy Research within the Myers-JDC-Brookdale Institute based in Jerusalem. Dr. Moore has served as a senior advisor to the biotechnology sector in Herzlia, Israel since 2005.

• Dr. Roscoe M. Moore, Jr. has been appointed Chief Scientific Director of MusclePharm Corporation which is headquartered in Denver, Colorado. MusclePharm is poised to enter the next generation of therapeutic nutritional supplementation to mitigate the impact and progression of wasting syndrome in HIV/AIDS patients. Unintentional and involuntary weight loss in people living with HIV/AIDS has long been recognized as a serious consequence of this disease. Dr. Moore is joining MusclePharm in order to provide the most effective evidence-based approach for its growth opportunities in the medical products community. Dr. Moore while serving as Assistant United States Surgeon General was responsible for joint HIV/AIDS programs between the U.S. Department of Health and Human Services and the U.S. Agency for International Development (USAID) in 40 countries on the Continent of Africa.

• On April 19, 2010, the Governor of the Central Bank of Nigeria, the Honorable Sanusi Lamido Aminu Sanusi, invited Dr. Roscoe M. Moore, Jr. and 40 others to attend a private dinner to discuss important advances in the banking system of Nigeria. He reported a 30 percent increase in revenue growth over the prior year. This event was sponsored by a number of global private companies, and was coordinated by the Constituency for Africa, a United States based advocacy organization for African interest. Dr. Moore serves on the Board of Directors for CFA.

• Dr. Roscoe M. Moore, Jr. has joined the Scientific Advisory Board of ImQuest Life Sciences of Frederick, Maryland. ImQuest is a privately held company, and a leading provider of anti-infective and anti-cancer drugs, and vaccine development services to the biotechnology and pharmaceutical industry. He joins Drs. David Ho (Aaron Diamond AIDS Research Center), Richard Whitley (University of Alabama, Birmingham), Robert Schooley (University of California, San Diego), Dan Van Hoff (Translational Genomics Research Institute, Phoenix), Albert LoBuglio (University of Alabama, Birmingham), and Edward Sausville (University of Maryland, Baltimore), who also serve on this board. ImQuest focuses on the development of novel therapies for diseases such as hepatitis B and C, cancer and HIV/AIDS. Dr. Moore is a former Assistant United States Surgeon General with a long and distinguished career in infectious and chronic disease epidemiology, cancer research, and public health.